Search results
Results from the WOW.Com Content Network
The subject expert committee of CDSCO has recommended the grant of permission for manufacturing and marketing of Desidustat 25 mg and 50 mg tablets in India, based on some conditions related to package insert, phase 4 protocols, prescription details, and GCP. [3] Clinical trials on desidustat have been done in India and Australia. [4]
Rilmenidine, an oxazoline compound with antihypertensive properties, acts on both medullary and peripheral vasomotor structures.. Rilmenidine is a imidazoline analog and shows greater selectivity for imidazoline receptors than for cerebral alpha2-adrenergic receptors, distinguishing it from reference alpha2-agonists, and conferring additional anti-inflammatory actions not shared with most ...
A combination drug (or fixed-dose combination; FDC) is a product that contains more than one active ingredient (e.g., one tablet, one capsule, or one syrup with multiple drugs). In naturopathy , dosages can take the form of decoctions and herbal teas , in addition to the more conventional methods mentioned above.
Tablets are often imprinted with symbols, letters, and numbers, which allow them to be identified, or a groove to allow splitting by hand. Sizes of tablets to be swallowed range from a few millimetres to about a centimetre. The compressed tablet is the most commonly seen dosage form in use today.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
[1] [55] [2] [54] With all dose levels, maximum inhibition is maintained for at least 48 hours after the dose. [1] [54] With repeated doses, rasagiline reaches greater than 99% platelet MAO-B inhibition after 6 days of 2 mg/day, 3 days of 5 mg/day, and 2 days of 10 mg/day. [1] [55] [54] Similarly, repeated administration of 0.5, 1, and 2 mg/day ...
In clinical pharmacology, dose refers to the amount of drug administered to a person, and dosage is a fuller description that includes not only the dose (e.g., "500 mg") but also the frequency and duration of the treatment (e.g., "twice a day for one week").
In the dose range, the mean half-life was 10.3 h. [2] Urine excretion was negligible amount in elimination of lobeglitazone in rat and human. [1] [2] The plasma protein binding of the drug is over 99%. [1] [6] The average blood-to-plasma concentration ratio was 0.636. The unbound fraction of lobeglitazone in microsomal incubation medium was 0.479.